Acknowledging no god but the corporate good, the shoshamen—high-powered professionals within Japan's integrated trading companies—serve as the unrelenting cogs of an economic machine. Or do they? Shoshaman takes us inside the world of Japan Inc. to explore the daily lives of the people who inhabit it. Written by a senior executive in a major sogo shosha, this absorbing novel reveals, as no textbook can, the strategies required to win the race to the top. It also makes painfully clear the ethical and psychological choices that such a race demands. The cast of characters is as varied as the corporate world itself, from the devoted Ojima, who has been passed over by the company, to the spirited Masako, who strikes out on her own. The hero, Nakasato Michio, finds that the road to success is long and perilous, as he tries to satisfy his ambitions while remaining faithful to his values. First published as Kigyoka sarariman in 1986 and made into a prize-winning television miniseries in 1988, the book has been acclaimed in Japan for the verisimilitude of its characters and situations. It offers a clear understanding of what it is like—in human terms—to survive and perhaps succeed within the confines of the Japanese corporation.
Shoshaman takes us inside Japan's integrated trading companies to explore the daily lives of the shoshamen, the high-powered pro-fessionals who make them work.
This book will provide readers with a detailed understanding of the ischemic damage to the myocardium after myocardial infarction, as well as essential tools for the treatment of damaged heart after myocardial infarction. It discusses various methods such as pharmacological pre- and post-conditioning, cytokine therapy, and cell therapy especially using Muse cells.The coverage of Muse cell therapy, which includes the latest work done by the author and his collaborators, is a unique feature of the book. Muse cells have self-renewability and have ability to differentiate into cells with the characteristics of all three germ layers from a single cell, while they are non-tumorigenic. It is the first book to feature the Muse cell therapy, which may offer the new promising therapeutic strategy for acute myocardial infarction.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.